Bogota, Colombia – Shanghai MicroPort Medical (Group) Co., Ltd. ("MicroPort®") recently obtained the regulatory approval from Colombia's health authority INVIMA for its in-house developed Firehawk® Rapamycin Target Eluting Coronary Stent System ("Firehawk®"). It is Firehawk®'s first registration certificate in Latin America that was gained through self-registration, with the holder of the certificate being "Shanghai MicroPort Medical (Group) Co., Ltd." Previously, Firehawk® has received approval in several other Latin American countries, such as Brazil, Mexico and Argentina.
The revolutionary third-generation DES Firehawk® is the result of eight years of research and development of MicroPort® and it is the world's first and only target eluting stent. As the world's lowest drug dosage stent, Firehawk® combines the merits of the bare metal stent and DES. It adopts unique in-groove abluminal coating design and target-eluting technique, which allow Firehawk® to achieve the same clinical efficacy with significantly low drug loading, benefiting vascular early healing.
As the third largest country in Latin America, Colombia has a population of 50 million with a huge, growing market for cardiovascular interventional products. Dated back to May 2016 when Mr. Ricardo Galindo Bueno, Colombian Consult General in Shanghai, visited MicroPort® headquarters, he showed his expectation in seeing MicroPort® products launched in Colombia, and suggested that the company may take Colombia as a good platform to further open markets in Central and South America to serve more patients. Dr. Linda Lin, First Vice President of MicroPort® International Business, said:" As we obtained the certificate through self-registration this time, we can more effectively expand the Colombian market with less external uncertainties. In the future, MicroPort® will introduce more high-end medical devices to Colombia and other Latin American countries to benefit more patients."
Privacy settings
This website may store cookies on your browser. Cookies are mostly used to make the website work as you expect it to. No cookie will directly identify you, but it can give you a more personalized browsing experience.
MicroPort respects your privacy rights, so you can block some types of cookies. Technically non-essential cookies and tracking mechanisms, that enable us to provide you with customized offers (marketing cookies), are only used if you have given prior consent to such use.
By clicking “Save”, only the cookies you selected will be used. You can withdraw the consent that you granted here at any time by going to Cookies Settings.
For more information, please see our Cookie Policy.